Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy
Keywords:
colectomy, ulcerative colitis, primary sclerosing cholangitis, outcomeAbstract
Background and Aim: Patients with ulcerative colitis (UC) are at risk of developing primary sclerosing cholangitis (PSC). As a form of continence preservation, ileal pouch-anal anastomosis or ileorectal anastomosis are used for patients undergoing colectomy. The present study aimed to determine the patient outcomes following colectomy for primary sclerosing cholangitis and ulcerative colitis. Patients and Methods: 64 patients with PSC and UC undergoing colectomy were enrolled and investigated in the Department of Gastroenterology, Lady Reading Hospital, Peshawar from January 2018 to June 2020. Study protocol was approved by the institutional research and ethical committee. Patient’s data regarding clinical information, preoperative liver tests, colectomy date, pathological findings, and follow-up liver tests were reviewed from medical records. The colectomy-leading indications such as colonic dysplasia, bowel perforation, and colonic inflammation etc. were recorded. Several preoperative tests were conducted, including total bilirubin, albumin levels, direct bilirubin and ALP. SPSS version 26 was used for data analysis. Results: The overall mean age was 40.42±3.6 years. Of the total 64 patients, there were 42 (65.6%) male and 22 (34.4%) females. Colectomy was most commonly indicated by severe intestinal inflammation (52%), bowel perforations (4%), and dysplastic colons (38%). The incidence of postoperative complications were 43.8% (n=28).
Downloads
References
Arhi C, Askari A, Nachiappan S, et al. Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease:A population-based study. J Crohns Colitis 2021;15(3):375–82.
Baek S-J, Lee KY, Song KH, et al. Current status and trends in inflammatory bowel disease surgery in Korea: Analysis of data in a nationwide registry. Ann Coloproctol 2018;34(6):299–305.
Bogach J, Pond G, Eskicioglu C, et al. Extent of surgical resection in inflammatory bowel disease associated colorectal cancer: A populationbased study. J Gastrointest Surg 2021;25(10):2610–8.
Bogach J, Pond G, Eskicioglu C, et al. Extent of surgical resection in inflammatory bowel disease associated colorectal cancer: A populationbased study. J Gastrointest Surg 2021;25(10):2610–8.
Castaño-Milla C, Chaparro M, Gisbert JP. Systematic review with metaanalysis: The declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014;39(7):645–59.
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-678.
De Vries EM, Verheij J, Hubscher SG, et al. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. J Hepatol. 2015;63:1212-1219.
Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease:A review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Phila) 2016;9(12):887–94.
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48(4):526–35.
Fevery J, van Steenbergen W, van Pelt J, et al. Patients with largeduct primary sclerosing cholangitis and Crohn’s disease have a better outcome than those with ulcerative colitis, or without IBD. Aliment Pharmacol Ther. 2016;43:612-620.
Gelley F, Miheller P, Péter A, Telkes G, Nemes B. Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience. Transplant Proc 2012; 44: 2164-2165.
Heuthorst L, Harbech H, Snijder HJ, Mookhoek A, D’Haens GR, Vermeire S, D’Hoore A, Bemelman WA, Buskens CJ. Increased Proportion of Colorectal Cancer in Patients with Ulcerative Colitis undergoing Surgery in the Netherlands. Official journal of the American College of Gastroenterology| ACG. 2022 May 12:10-4309.
Jakobsson GL, Sternegard E, Olen O, et al. Validating inflammatory bowel disease (IBD) in the Swedish national patient register and the Swedish quality register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52:216-221.
Jess T, Rungoe C, Peyrin–Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: A meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012;10(6):639–45.
Khan N, Cole E, Shah Y, et al. Segmental resection is a safe oncological alternative to total proctocolectomy in elderly patients with ulcerative colitis and malignancy. Colorectal Dis 2017;19(12):1108–16.
Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Primers 2020;6(1):74.
Lutgens MWMD, van Oijen MGH, van der Heijden GJMG, et al. Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19(4):789–99.
Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis 2017;11(6):649–70.
Ni A, Al-Qahtani M, Salama E, et al. Trends in colectomies for colorectal neoplasms in ulcerative colitis: A national inpatient sample database analysis over two decades. J Gastrointest Surg 2020;24(8):1721–8.
Nordenvall C, Olén O, Nilsson PJ, von Seth E, Ekbom A, Bottai M, Myrelid P, Bergquist A. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC‐IBD patients. Alimentary Pharmacology & Therapeutics. 2018 Jan;47(2):238-45.
Olen O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: A scandinavian population-based cohort study. Lancet2020;395(10218):123–31.
Øresland T, BemelmanWA, Sampietro GM, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis 2015;9(1):4–25.
Reijntjes MA, Heuthorst L, Gecse K, Mookhoek A, Bemelman WA, Buskens CJ. Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients. Therapeutic advances in gastroenterology. 2022 Jun; 15:17562848221098849.
Remzi FH, Lavryk OA, Ashburn JH, et al. Restorative proctocolectomy: An example of how surgery evolves in response to paradigm shifts in care. Colorectal Dis 2017;19(11):1003–12.
Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: Ulcerative colitis in adults. Am J Gastroenterol 2019;114(3): 384–413.
Runde J, Erondu A, Akiyama S, Traboulsi C, Rai V, Glick LR, Yi Y, Ollech JE, Cohen RD, Skowron KB, Hurst RD. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch–Anal Anastomosis in Pediatric Ulcerative Colitis. Inflammatory bowel diseases. 2022 Sep;28(9):1386-94.
Sathiaseelan M, Bolia R, Barallon R, Alex G, Hardikar W, Rajanayagam J. Impact of ulcerative colitis on liver‐related outcomes of children with primary sclerosing cholangitis. Journal of Paediatrics and Child Health. 2022 Jul;58(7):1221-7.
Treeprasertsuk S, Björnsson E, Sinakos E, Weeding E, Lindor KD. Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy. World J Gastrointest Pharmacol Ther 2013; 4(3): 61-68 DOI: http://dx.doi.org/10.4292/wjgpt.v4.i3.61.
Uchino M, Ikeuchi H, Hata K, et al. Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study. Surg Today 2019;49(12):1066–73.
Van den Heuvel TRA, Jeuring SFG, Zeegers MP, et al. A 20-year temporal change analysis in incidence, presenting phenotype and mortality, in the Dutch IBDSL cohort-can diagnostic factors explain the increase in IBD incidence? J Crohns Colitis 2017;11(10):1169–79.
Vesterhus M, Hov JR, Holm A, et al. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis. Hepatology. 2015;62:188-197.
Zheng HH, Jiang XL. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. Eur J Gastroenterol Hepatol. 2016;28:383-390.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
